ciprofloxacin has been researched along with telaprevir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ba, MY; Cheng, W; Duan, YT; Li, HL; Sun, MR; Zhu, HL | 1 |
1 review(s) available for ciprofloxacin and telaprevir
| Article | Year |
|---|---|
Cyclopropyl Scaffold: A Generalist for Marketed Drugs.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cyclopropanes; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Gram-Positive Bacteria; Hepacivirus; Humans; Oligopeptides; Viral Nonstructural Proteins | 2021 |
1 other study(ies) available for ciprofloxacin and telaprevir
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |